Inhibition of the B cell associated tyrosine kinase SYK as a potential therapeutic target in aggressive lymphomas.

被引：0
|
作者：
Bertoni, F
Ridaidi, A
Sasso, A
Uccella, S
Martin, V
Napoli, S
Pruneri, G
Zucca, E
Capella, C
Catapano, CV
Tibiletti, MG
Cavalli, F
机构：
[1] Oncol Inst Sos Switzerland, Expt Oncol Lab, Bellinzona, Switzerland
[2] Oncol Inst Sos Switzerland, Lymphoma Unit, Bellinzona, Switzerland
[3] Univ Insubria, Osped Circolo, Anat Pathol Unit, Varese, Italy
[4] European Inst Oncol, Div Pathol & Lab Med, Milan, Italy
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1469
引用
收藏
页码：424A / 424A
页数：1
相关论文
共 50 条
  • [21] Prohibitin: a potential therapeutic target in tyrosine kinase signaling
    Ande, Sudharsana Rao
    Xu, Yang Xin Zi
    Mishra, Suresh
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2017, 2
  • [22] Prohibitin: a potential therapeutic target in tyrosine kinase signaling
    Sudharsana Rao Ande
    Yang Xin Zi Xu
    Suresh Mishra
    Signal Transduction and Targeted Therapy, 2
  • [23] Allogeneic and Autologous Transplantation In Patients with Aggressive B- and T-Cell Lymphomas.
    Schueler, Frank
    Hoffmann, Madelaine
    Pfrepper, Christian
    Daneschnejad, Said
    Lange, Thoralf
    Poenisch, Wolfram
    Al-Ali, Haifa K.
    Niederwieser, Dietger W.
    Basara, Nadezda
    BLOOD, 2010, 116 (21) : 1458 - 1458
  • [24] The risk related BAL gene increases the migration of aggressive B-cell lymphomas.
    Aguiar, RCT
    Yakushijin, Y
    Kharbanda, S
    Fletcher, J
    Salgia, R
    Shipp, MA
    BLOOD, 1999, 94 (10) : 699A - 699A
  • [25] Inhibiting recognition of the B-cell receptor by the tyrosine kinase Syk
    Horton, Timothy M.
    Visperas, Patrick R.
    Kuriyan, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [26] Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients
    Braegelmann, C.
    Hoelzel, M.
    Ludbrook, V.
    Dickson, M.
    Turan, N.
    Ferring-Schmitt, S.
    Sternberg, S.
    Bieber, T.
    Kuhn, A.
    Wenzel, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 6 - 6
  • [27] Analysis of prognostic factors in patients with HIV-associated aggressive B-cell non-Hodgkin lymphomas.
    Mathew, Blessy Maria
    Dalia, Samir
    Hall, Joseph
    Kuykendall, Andrew
    Shah, Bijal D.
    Bello, Celeste M.
    Chervenick, Paul A.
    Sokol, Lubomir
    Sotomayor, Eduardo M.
    Chavez, Julio C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients
    Braegelmann, Christine
    Hoelzel, Michael
    Ludbrook, Valerie
    Dickson, Marion
    Turan, Nil
    Ferring-Schmitt, Sandra
    Sternberg, Sonja
    Bieber, Thomas
    Kuhn, Annegret
    Wenzel, Joerg
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (05) : 375 - 379
  • [29] EBV driven gene therapy for EBV associated B cell lymphomas.
    Franken, M
    Estabrook, A
    Cavacini, L
    Sherbourne, B
    Wang, F
    Scadden, D
    BLOOD, 1995, 86 (10) : 2493 - 2493
  • [30] Syk Tyrosine Kinase Is Critical for B Cell Antibody Responses and Memory B Cell Survival
    Ackermann, Jochen A.
    Nys, Josquin
    Schweighoffer, Edina
    McCleary, Scott
    Smithers, Nicholas
    Tybulewicz, Victor L. J.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (10): : 4650 - 4656
12345